UNIQA continues to execute well on its 2025-2028 strategic targets, with improving non-life profitability and expanding life and health business segments. Positive trends should drive an EPS CAGR of 8.3%, on a par with Triglav Group, and above the AT&CEE average of 6.8% and we believe UNIQA is likely to upgrade its mid-term targets. The stock offers an attractive dividend yield of 6% and despite the 65% YTD return, our valuation analysis still indicates above 10% upside from current levels. We c...
A director at Uniqa Insurance Group AG bought 1,613 shares at 12.451EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.